Department of Family Medicine and Primary Health Care, Kowloon West Cluster, Hong Kong.
Hong Kong Med J. 2012 Jun;18(3):193-200.
To estimate the point prevalence of primary hyperaldosteronism in a government out-patient setting and to compare associated patient characteristics with those having essential hypertension.
Case series with external comparison.
A single public hospital (Caritas Medical Centre) and all five associated general out-patient clinics in Sham Shui Po district in Hong Kong.
All patients with confirmed primary hyperaldosteronism and randomly selected patients with essential hypertension from a medical specialist clinic and general out-patient clinics, retrieved from a computer database for the period January 2007 to December 2008.
Estimated point prevalence of primary hyperaldosteronism among hypertensive patients treated in the public sector of Sham Shui Po district. Patient age when hypertension was diagnosed, number of antihypertensive drugs used for treatment, and the presence of target organ damage in the patients with primary hyperaldosteronism and those with essential hypertension were compared.
Among the 46 012 patients receiving antihypertensive treatment, 49 were confirmed to have primary hyperaldosteronism. The estimated point prevalence of primary hyperaldosteronism among these hypertensive patients was 0.106% only, which was far smaller than figures from other countries. When compared with the 147 patients with essential hypertension by multivariate analysis, those with primary hyperaldosteronism were: (1) associated with longer durations of hypertension (odds ratio=1.14; 95% confidence interval, 1.06-1.24) despite being younger at the time of study, (2) likely to be taking three or more antihypertensive drugs (odds ratio=2.51; 95% confidence interval, 1.59-3.95), and (3) more likely to have left ventricular hypertrophy (odds ratio=5.01; 95% confidence interval, 1.83-13.69). All primary hyperaldosteronism patients studied presented with hypokalaemia. The need for antihypertensive drugs was markedly reduced after adrenalectomy for adrenal adenoma.
Primary hyperaldosteronism, which is potentially a surgically curable cause of hypertension, appeared to be underdiagnosed in our locality. Screening by aldosterone-renin ratio of high-risk individuals may help improve patient outcomes.
评估政府门诊原发性醛固酮增多症的现患率,并比较其与原发性高血压患者的相关特征。
病例系列,外部对照。
香港深水埗区的一家公立医院(明爱医院)和与之相关的五家普通门诊。
2007 年 1 月至 2008 年 12 月期间,从计算机数据库中检索到经证实患有原发性醛固酮增多症的所有患者和从医学专家诊所和普通门诊随机选择的患有原发性高血压的患者。
评估在深水埗区公立医院接受治疗的高血压患者中原发性醛固酮增多症的现患率。比较原发性醛固酮增多症患者和原发性高血压患者的高血压确诊年龄、降压药使用数量和靶器官损害情况。
在接受降压治疗的 46012 名患者中,有 49 例被确诊为原发性醛固酮增多症。这些高血压患者中原发性醛固酮增多症的估计现患率仅为 0.106%,远低于其他国家的数值。通过多变量分析与 147 例原发性高血压患者相比,原发性醛固酮增多症患者:(1)尽管在研究时年龄较小,但高血压持续时间更长(比值比=1.14;95%置信区间,1.06-1.24);(2)更可能使用三种或更多种降压药物(比值比=2.51;95%置信区间,1.59-3.95);(3)更可能出现左心室肥厚(比值比=5.01;95%置信区间,1.83-13.69)。所有研究的原发性醛固酮增多症患者均表现为低钾血症。肾上腺腺瘤切除术后,对降压药物的需求明显减少。
在我们的地区,原发性醛固酮增多症是一种潜在的可手术治愈的高血压病因,但似乎诊断不足。通过醛固酮-肾素比值对高危人群进行筛查可能有助于改善患者的结局。